Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.82 USD | -0.02% | +6.44% | +167.33% |
Apr. 04 | Avidity Biosciences Insider Sold Shares Worth $734,919, According to a Recent SEC Filing | MT |
Apr. 04 | Avidity Biosciences Insider Sold Shares Worth $542,214, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+167.33% | 2.28B | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-19.48% | 29.48B | |
+57.86% | 25.43B | |
-17.75% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- RNA Stock
- News Avidity Biosciences, Inc.
- Avidity Biosciences : Says FDA Grants its AOC 1001 Myotonic Dystrophy Type 1 Treatment Fast-Track Designation